Evidence map›Paper›PMID 27822179›Full record

ArticleFrontiers in cellular neuroscience2016

Plasmid-Based Generation of Induced Neural Stem Cells from Adult Human Fibroblasts.

Philipp Capetian, Luis Azmitia, Martje G Pauly, Victor Krajka, Felix Stengel, Eva-Maria Bernhardi, Mariana Klett, Britta Meier, Philip Seibler, Nancy Stanslowsky and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2020
    Review
  13. Therapeutic Plasticity of Neural Stem Cells.Frontiers in neurology · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Philipp CapetianInstitute of Neurogenetics, University of LübeckLübeck, Germany; Department of Neurology, University of LübeckLübeck, Germany.
Luis AzmitiaDepartment of Neurosurgery, University of Kiel Kiel, Germany.
Martje G PaulyInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Victor KrajkaInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Felix StengelInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Eva-Maria BernhardiInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Mariana KlettLaboratory of Stereotaxy and Interventional Neuroscience, Department of Stereotactic and Functional Neuroscience, University Medical Center Freiburg Freiburg im Breisgau, Germany.
Britta MeierInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Philip SeiblerInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
Nancy StanslowskyDepartment of Neurology, Hannover Medical School Hanover, Germany.
Andreas MoserDepartment of Neurology, University of Lübeck Lübeck, Germany.
Andreas KnoppInstitute of Physiology, University of Kiel Kiel, Germany.
Gabriele Gillessen-KaesbachInstitute of Human Genetics, University of Lübeck Lübeck, Germany.
Guido NikkhahDepartment of Neurosurgery, University of Erlangen-Nuremberg Erlangen, Germany.
Florian WegnerDepartment of Neurology, Hannover Medical School Hanover, Germany.
Máté DöbrössyLaboratory of Stereotaxy and Interventional Neuroscience, Department of Stereotactic and Functional Neuroscience, University Medical Center Freiburg Freiburg im Breisgau, Germany.
Christine KleinInstitute of Neurogenetics, University of Lübeck Lübeck, Germany.
University of Lübeck · DEKiel University · DEMedizinische Hochschule Hannover · DEUniversity Medical Center Freiburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Direct reprogramming from somatic to neural cell types has become an alternative to induced pluripotent stem cells. Most protocols employ viral expression systems, posing the risk of random genomic integration. Recent developments led to plasmid-based protocols, lowering this risk. However, these protocols either relied on continuous presence of a variety of small molecules or were only able to reprogram murine cells. We therefore established a reprogramming protocol based on vectors containing the Epstein-Barr virus (EBV)-derived oriP/EBNA1 as well as the defined expression factors Oct3/4, Sox2, Klf4, L-myc, Lin28, and a small hairpin directed against p53. We employed a defined neural medium in combination with the neurotrophins bFGF, EGF and FGF4 for cultivation without the addition of small molecules. After reprogramming, cells demonstrated a temporary increase in the expression of endogenous Oct3/4. We obtained induced neural stem cells (iNSC) 30 days after transfection. In contrast to previous results, plasmid vectors as well as a residual expression of reprogramming factors remained detectable in all cell lines. Cells showed a robust differentiation into neuronal (72%) and glial cells (9% astrocytes, 6% oligodendrocytes). Despite the temporary increase of pluripotency-associated Oct3/4 expression during reprogramming, we did not detect pluripotent stem cells or non-neural cells in culture (except occasional residual fibroblasts). Neurons showed electrical activity and functional glutamatergic synapses. Our results demonstrate that reprogramming adult human fibroblasts to iNSC by plasmid vectors and basic neural medium without small molecules is possible and feasible. However, a full set of pluripotency-associated transcription factors may indeed result in the acquisition of a transient (at least partial) pluripotent intermediate during reprogramming. In contrast to previous reports, the EBV-based plasmid system remained present and active inside the cells at all time points.

Indexed as

adult human fibroblastsdirect reprogrammingepisomal vectorsinduced neural stem cellslineage conversionplasmid based reprogramming

Identifiers

PMID27822179
PMCPMC5075569
OpenAlexW2536318232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.